💡 key considerations for dosage regimen patents – a comparative analysis of epo, uk, and us case law
Published 1 month ago • 153 plays • Length 49:56Download video MP4
Download video MP3
Similar videos
-
4:02
💡 patent validation in europe #rolfclaessen
-
14:50
💡 epo landmark decision g2/21 – interview with the opponent syngenta! #rolfclaessen
-
53:51
the iso 15189 : 2022laboratory accreditation analytical quality requirement
-
30:03
et480 smartwatch | non-invasive blood glucose uric acid lipids hr spo2 body temp body composition
-
1:00:05
advanced topics in patent law: patent and fda strategies for new drugs
-
0:16
introducing our new drug-nutrient interaction checker for healthcare professionals
-
4:19
common types of pharmaceutical patents
-
2:36
helsinn healthcare s.a. v. teva pharm. usa, inc. (2017) case brief summary | law case explained
-
3:54
cooperative patent classification (cpc)
-
23:10
is recent patent case-law good for precision medicine? - mateo aboy
-
3:26
what is a patent - patent definition - patents basics #patent #rolfclaessen
-
2:01
pharmacy processes prescriptions more efficiently, improved patient safety with e-prescribing
-
4:35
💡 obviousness or inventive step - how the epo determines inventive step #rolfclaessen
-
1:02
jaan leis, mati arulepp & anti perkson: superior carbon-based materials for ultracapacitors
-
![using a ‘3c-strategy’ to identify keystone taxa from a benzo[a]pyrene degradative microbiome](https://i.ytimg.com/vi/yb3HvhZM2wU/mqdefault.jpg)
1:51
using a ‘3c-strategy’ to identify keystone taxa from a benzo[a]pyrene degradative microbiome